15.00
0.86%
-0.13
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$15.13
Offen:
$14.91
24-Stunden-Volumen:
84,782
Relative Volume:
2.14
Marktkapitalisierung:
$277.13M
Einnahmen:
$445.32M
Nettoeinkommen (Verlust:
$15.08M
KGV:
56.69
EPS:
0.2646
Netto-Cashflow:
$30.75M
1W Leistung:
-3.91%
1M Leistung:
-6.25%
6M Leistung:
-0.13%
1J Leistung:
-14.38%
Natures Sunshine Products Inc Stock (NATR) Company Profile
Firmenname
Natures Sunshine Products Inc
Sektor
Branche
Telefon
(801) 341-7900
Adresse
2901 WEST BLUEGRASS BLVD., LEHI
Vergleichen Sie NATR mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
NATR
Natures Sunshine Products Inc
|
15.00 | 277.13M | 445.32M | 15.08M | 30.75M | 0.77 |
KHC
Kraft Heinz Co
|
30.52 | 36.90B | 26.13B | 1.37B | 3.00B | 1.11 |
GIS
General Mills Inc
|
63.61 | 35.06B | 19.90B | 2.60B | 2.80B | 4.60 |
K
Kellanova Co
|
80.50 | 27.75B | 12.80B | 1.01B | 927.00M | 2.91 |
MKC
Mccormick Co Inc
|
78.86 | 21.16B | 6.68B | 792.60M | 774.40M | 2.94 |
HRL
Hormel Foods Corp
|
31.68 | 17.39B | 11.92B | 805.04M | 1.01B | 1.46 |
Natures Sunshine Products Inc Stock (NATR) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-09-13 | Eingeleitet | Canaccord Genuity | Buy |
2021-10-15 | Eingeleitet | DA Davidson | Buy |
2015-04-09 | Eingeleitet | Imperial Capital | In-line |
2014-06-02 | Eingeleitet | Singular Research | Buy |
2013-03-08 | Bestätigt | Imperial Capital | In-line |
Natures Sunshine Products Inc Aktie (NATR) Neueste Nachrichten
BNP Paribas Financial Markets Sells 11,283 Shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR) - Defense World
Undiscovered Gems In The US Market Nature's Sunshine Products And Two More Promising Small Caps - Simply Wall St
Nature’s Sunshine Named Nutrition Sponsor of Cirque Series - Direct Selling News
Nature's Sunshine Partners with Cirque Series to Push Peaks 2025-2027 - The Manila Times
Nature’s Sunshine Partners with Cirque Series to Push Peaks 2025-2027 - GlobeNewswire
Nature's Sunshine Secures Title Sponsorship of Premier U.S. Mountain Race Series Cirque - StockTitan
Nature's Sunshine Products, Inc.'s (NASDAQ:NATR) 28% Share Price Surge Not Quite Adding Up - Simply Wall St
Wasatch Advisors LP Grows Stock Holdings in Nature's Sunshine Products, Inc. (NASDAQ:NATR) - MarketBeat
Nature's Sunshine Products, Inc. (NASDAQ:NATR) Short Interest Update - MarketBeat
Returns At Nature's Sunshine Products (NASDAQ:NATR) Are On The Way Up - Yahoo Finance
Estee Lauder Companies (EL-N) QuotePress Release - The Globe and Mail
Nu Skin Enterprises (NUS-N) QuotePress Release - The Globe and Mail
The Honest Company (NASDAQ:HNST) Q3 Earnings: Leading The Personal Care Pack - Financial Content
The Honest Company (HNST-Q) QuotePress Release - The Globe and Mail
TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail
Personal Care Stocks Q3 Recap: Benchmarking Nature's Sunshine (NASDAQ:NATR) - Yahoo Finance
Emerging Small Caps to Explore in November 2024 - Simply Wall St
Nature's Sunshine Products stock target raised, holds buy on strong sales - Investing.com
Nature's Sunshine Appoints Steven Fasching to Board of Directors - The Manila Times
Nature’s Sunshine Appoints Steven Fasching to Board of Directors - GlobeNewswire
Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Q3 2024 Earnings Call Transcript - Insider Monkey
Nature S Sunshine (NATR-Q) QuotePress Release - The Globe and Mail
Natures Sunshine Products Inc (NATR) Q3 2024 Earnings Call Highlights: Strong Asia Pacific ... By GuruFocus - Investing.com Canada
Natures Sunshine Products Inc (NATR) Q3 2024 Earnings Call Highl - GuruFocus.com
Natures Sunshine Products Inc (NATR) Q3 2024 Earnings Call Highlights: Strong Asia Pacific ... - Yahoo Finance
Nature's Sunshine: Q3 Earnings Snapshot - Houston Chronicle
Nature's Sunshine Products, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Nature's Sunshine (NASDAQ:NATR) Surprises With Strong Q3, Full-Year Sales Guidance Is Optimistic - Yahoo Finance
Nature's Sunshine Reports Third Quarter 2024 Results - The Manila Times
Herbalife Ltd (HLF-N) QuotePress Release - The Globe and Mail
Natures Sunshine Products Inc (NATR) Q3 2024 Earnings Report Pre - GuruFocus.com
Natures Sunshine Products Inc (NATR) Q3 2024 Earnings Report Preview: What to Look For - Yahoo Finance
Nature's Sunshine (NATR) Q3 Earnings Report Preview: What To Look For - Yahoo Finance
Nature's Sunshine Products (NATR) Set to Announce Quarterly Earnings on Thursday - MarketBeat
Nature’s Sunshine Sets Third Quarter 2024 Conference Call for Thursday, November 7, 2024, at 5:00 p.m. ET - GlobeNewswire
Multivitamin Capsules Tablets Market May Set Epic Growth Story | Amway, Abbott, Pfizer, Bayer, ADM - openPR
Shanghai Fosun Pharmaceutical sells $29,946 in Natures Sunshine products stock - Investing.com UK
Nature's Sunshine Products: Cheap, But Not Entirely Without A Reason To Be (NATR) - Seeking Alpha
Elanco Animal Health (ELAN) Stock Drops 5% Amidst Industry Decli - GuruFocus.com
OTC Multivitamins And Minerals Supplements Market 2024 Segments Analysis by Top Key Players:Amway, Abbott, Bayer AG, Gla – IndiaPolitics.com - IndiaPolitics.com
Nature’s Sunshine Products (NASDAQ:NATR) Share Price Crosses Below 200 Day Moving Average – Time to Sell? - Defense World
Fosun pharmaceutical sells shares in Natures Sunshine Products for $145,188 - Investing.com India
Fosun Pharmaceutical Shanghai Sells 1,300 Shares of Nature's Sunshine Products, Inc. (NASDAQ:NATR) Stock - MarketBeat
Nature's Sunshine Products (NASDAQ:NATR) Stock Price Crosses Below 200-Day Moving AverageHere's Why - MarketBeat
Herbal Weight Loss Products Industry Size, Share, Price, Trends, Forecast (2024-2034) - IndiaPolitics.com
Finanzdaten der Natures Sunshine Products Inc-Aktie (NATR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Natures Sunshine Products Inc-Aktie (NATR) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 10 '24 |
Sale |
13.39 |
3,000 |
40,170 |
69,347 |
Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 09 '24 |
Sale |
13.36 |
1,816 |
24,262 |
72,347 |
Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 08 '24 |
Sale |
13.13 |
1,800 |
23,634 |
74,163 |
Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 11 '24 |
Sale |
13.37 |
1,580 |
21,125 |
67,767 |
Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 01 '24 |
Sale |
13.54 |
1,399 |
18,942 |
75,963 |
Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 14 '24 |
Sale |
13.12 |
1,300 |
17,056 |
66,467 |
Yates Bryant J | EVP & President, Europe |
Jun 06 '24 |
Sale |
15.30 |
3,068 |
46,940 |
98,852 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):